181 related articles for article (PubMed ID: 26282606)
1. Lung adenocarcinoma: Are skip N2 metastases different from non-skip?
Li H; Hu H; Wang R; Li Y; Shen L; Sun Y; Chen H
J Thorac Cardiovasc Surg; 2015 Oct; 150(4):790-5. PubMed ID: 26282606
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas.
Guerrera F; Renaud S; Tabbó F; Voegeli' AC; Filosso PL; Legrain M; Boita M; Schaeffer M; Beau-Faller M; Ruffini E; Falcoz PE; Inghirami G; Oliaro A; Massard G
Eur J Cardiothorac Surg; 2017 Apr; 51(4):680-688. PubMed ID: 28329143
[TBL] [Abstract][Full Text] [Related]
3. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
4. Skip N2 Metastasis in Pulmonary Adenocarcinoma: Good Prognosis Similar to N1 Disease.
Wang L; Ye G; Xue L; Zhan C; Gu J; Xi J; Lin Z; Jiang W; Ge D; Wang Q
Clin Lung Cancer; 2020 Sep; 21(5):e423-e434. PubMed ID: 32245623
[TBL] [Abstract][Full Text] [Related]
5. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
6. Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients.
Li X; Li X; Fu X; Liu L; Liu Y; Zhao H; Li Y; Hu J; Xu L; Liu D; Yang H; Zhang X
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1874-1881. PubMed ID: 31902592
[TBL] [Abstract][Full Text] [Related]
7. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
[TBL] [Abstract][Full Text] [Related]
8. Role of skip N2 lymph node metastasis for patients with the stage III-N2 lung adenocarcinoma: a propensity score matching analysis.
Wang S; Xie S; Han Y; Gao M; Su X; Liu Q
BMC Pulm Med; 2023 Apr; 23(1):147. PubMed ID: 37118722
[TBL] [Abstract][Full Text] [Related]
9. Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer.
Ilic N; Petricevic A; Arar D; Kotarac S; Banovic J; Ilic NF; Tripkovic A; Grandic L
J Thorac Oncol; 2007 Nov; 2(11):1018-21. PubMed ID: 17975493
[TBL] [Abstract][Full Text] [Related]
10. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
[TBL] [Abstract][Full Text] [Related]
11. Skip mediastinal nodal metastases in non-small cell lung cancer.
Tanaka F; Takenaka K; Oyanagi H; Fujinaga T; Otake Y; Yanagihara K; Ito H; Wada H
Eur J Cardiothorac Surg; 2004 Jun; 25(6):1114-20. PubMed ID: 15145018
[TBL] [Abstract][Full Text] [Related]
12. Role of Skip Mediastinal Lymph Node Metastasis for Patients With Resectable Non-small-cell Lung Cancer: A Propensity Score Matching Analysis.
Wang L; Zhan C; Gu J; Xi J; Lin Z; Xue L; Ge D; Wang Q
Clin Lung Cancer; 2019 May; 20(3):e346-e355. PubMed ID: 30665872
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features of skip metastasis in colorectal cancer.
Shiozawa M; Akaike M; Yamada R; Godai T; Yamamoto N; Saito H; Sugimasa Y; Takemiya S; Rino Y; Imada T
Hepatogastroenterology; 2007; 54(73):81-4. PubMed ID: 17419236
[TBL] [Abstract][Full Text] [Related]
14. Skip mediastinal lymph node metastasis in non-small cell lung cancer.
Tateishi M; Fukuyama Y; Hamatake M; Kohdono S; Ishida T; Sugimachi K
J Surg Oncol; 1994 Nov; 57(3):139-42. PubMed ID: 7967601
[TBL] [Abstract][Full Text] [Related]
15. Impact of skip mediastinal lymph node metastasis on outcomes after resection for primary lung cancer.
Taylor M; Soliman N; Paoletti E; King M; Crosbie PAJ; Granato F
Lung Cancer; 2023 Oct; 184():107341. PubMed ID: 37573704
[TBL] [Abstract][Full Text] [Related]
16. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between Lymph Node Ratio and Clinicopathological Features and Prognosis of IIIa-N2 Non-small Cell Lung Cancer].
Zhang S; Wang L; Lu F; Pei Y; Yang Y
Zhongguo Fei Ai Za Zhi; 2019 Nov; 22(11):702-708. PubMed ID: 31771739
[TBL] [Abstract][Full Text] [Related]
18. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Significance of Metastasis to Lymph Nodes in Aortopulmonary Zone (Stations 5 and 6) in Completely Resected Left Upper Lobe Tumors.
Citak N; Sayar A; Metin M; Büyükkale S; Kök A; Solak O; Yurt S; Gürses A
Thorac Cardiovasc Surg; 2015 Oct; 63(7):568-76. PubMed ID: 25893919
[TBL] [Abstract][Full Text] [Related]
20. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
